BOSTON, Oct. 22 /PRNewswire/ -- TEI Biosciences Inc. today announced the introduction of its newest product line, SurgiMend(R) PRS for Breast Reconstruction, a superior biologic mesh that will be featured at the ASPS Plastic Surgery 2009 Conference in Seattle, October 23-26.
(Photo: http://www.newscom.com/cgi-bin/prnh/20091022/NE97736-b )
(Logo: http://www.newscom.com/cgi-bin/prnh/20091022/NE97736LOGO-a )
SurgiMend PRS is designed specifically for breast reconstruction and is comprised of the same natural collagen matrix found in TEI’s clinically-proven, non-inflammatory soft tissue repair and reconstruction products that have been used successfully in over 100,000 patients worldwide.
Located in Booth 2141, TEI will introduce the SurgiMend PRS product line to surgeons through demonstrations and presentations. SurgiMend PRS is available in three unique shapes and sizes to accommodate a wide range of expanders, implants and techniques: a 7 x 17 cm rectangle; a 10 x 15 cm semi-oval; and a 10 x 20 cm rectangle, all of which are available with fenestrations to assist with fluid drainage, provide gradual stretch, and improve incorporation. SurgiMend PRS was developed with extensive input from breast reconstruction surgeons.
“The launch of SurgiMend PRS for Breast Reconstruction represents the latest addition to our growing SurgiMend product family and underscores our ongoing commitment to developing biologic products that meet the evolving medical needs of surgeons and their patients,” commented Yiannis Monovoukas, Ph.D., TEI’s Chairman, President & CEO. “With the new SurgiMend PRS sizes and designs, plastic surgeons now have a superior choice in biologic mesh devices for reconstruction of the breast post-mastectomy - an all-natural product based on a proven technology,” said Dr. Monovoukas.
About SurgiMend(R) Collagen Matrix
SurgiMend is derived from the dermis of fetal or neonatal calves, is an all-natural implantable collagen matrix that is non-inflammatory, non-toxic, non-crosslinked, and terminally-sterilized. It is intrinsically strong yet pliable with excellent handling and suturing characteristics. It hydrates quickly and, upon implantation, is rapidly vascularized and incorporated into native tissues. SurgiMend has higher levels of collagen Type III, the collagen type found in developing and healing tissues, than any other biologic mesh currently on the market.
About SurgiMend((R) )PRS for Breast Reconstruction
SurgiMend PRS is comprised of the same SurgiMend Collagen Matrix, with two notable new features: first, SurgiMend PRS is available in three unique shapes and sizes that easily conform to breast contours and provide sound structural support during healing. Second, SurgiMend PRS incorporates a dense network of fenestrations, as fenestrations have been shown to assist in fluid drainage and to improve vascularization and incorporation, while also providing gradual and directional stretching as needed when used with expanders. For more information on SurgiMend PRS for Breast Reconstruction, please visit www.teibio.com/PRS.
About TEI Biosciences Inc.
A Boston-based, privately-held, leading biomedical company, TEI Biosciences Inc. (www.teibio.com) has applied its expertise in regenerative medicine to develop and commercialize novel biologic products for a broad spectrum of soft tissue repair, regeneration, and reinforcement applications - from plastic and reconstructive surgery to dura, tendon, and hernia repair and wound management.
TEI sells its products directly and through partnerships with some of the world’s major medical device companies. TEI’s marketed products include:
SOURCE TEI Biosciences Inc.
CONTACT: Yiannis Monovoukas, Ph.D., ymonovoukas@teibio.com, or Diane Kemp,
+1-617-268-1616 x. 241, dkemp@teibio.com, both of TEI Biosciences Inc.
Web site: http://www.teibio.com/
